Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?

Saada-Bouzid, Esma; Peyrade, Frederic; Guigay, Joël

Saada-Bouzid, Esma; Peyrade, Frederic; Guigay, Joël.

Affiliation

Saada-Bouzid E; Department of Medical Oncology, Centre Antoine Lacassagne.
Peyrade F; Université Côte d'Azur, Nice, France.
Guigay J; Department of Medical Oncology, Centre Antoine Lacassagne.

Curr Opin Oncol ; 34(3): 196-203, 2022 05 01.

Article in En | MEDLINE | ID: mdl-35671120

Subject(s)

Head and Neck Neoplasms; Neoplasm Recurrence, Local; Fluorouracil/therapeutic use; Head and Neck Neoplasms/drug therapy; Humans; Immune Checkpoint Inhibitors; Neoplasm Recurrence, Local/drug therapy; Neoplasm Recurrence, Local/pathology; Nivolumab/therapeutic use; Squamous Cell Carcinoma of Head and Neck/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Head and Neck Neoplasms / Neoplasm Recurrence, Local Limits: Humans Language: En Journal: Curr Opin Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google